Glycomacropeptide in PKU—Does It Live Up to Its Potential?
Sign Up to like & getrecommendations! Published in 2022 at "Nutrients"
DOI: 10.3390/nu14040807
Abstract: The use of casein glycomacropeptide (CGMP) as a protein substitute in phenylketonuria (PKU) has grown in popularity. CGMP is derived from κ casein and is a sialic-rich glycophosphopeptide, formed by the action of chymosin during… read more here.
Keywords: pku; cgmp; live potential; glycomacropeptide pku ... See more keywords